216 related articles for article (PubMed ID: 34315950)
1. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
[TBL] [Abstract][Full Text] [Related]
2. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
[TBL] [Abstract][Full Text] [Related]
3. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
[TBL] [Abstract][Full Text] [Related]
4. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNAs for the early diagnosis of Parkinson's disease and multiple system atrophy.
Yan JH; Hua P; Chen Y; Li LT; Yu CY; Yan L; Zhang H; He Y; Zheng H; Chen H; Zhang ZJ; Yao QH; Dong H; Liu WG
J Integr Neurosci; 2020 Sep; 19(3):429-436. PubMed ID: 33070521
[TBL] [Abstract][Full Text] [Related]
7. Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.
Chen L; Yang J; Lü J; Cao S; Zhao Q; Yu Z
Brain Behav; 2018 Apr; 8(4):e00941. PubMed ID: 29670823
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
[TBL] [Abstract][Full Text] [Related]
10. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
[TBL] [Abstract][Full Text] [Related]
11. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
[TBL] [Abstract][Full Text] [Related]
12. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
[TBL] [Abstract][Full Text] [Related]
13. Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease.
Zhang X; Yang R; Hu BL; Lu P; Zhou LL; He ZY; Wu HM; Zhu JH
Front Cell Neurosci; 2017; 11():170. PubMed ID: 28690499
[TBL] [Abstract][Full Text] [Related]
14. Combinatory microRNA serum signatures as classifiers of Parkinson's disease.
Patil KS; Basak I; Dalen I; Hoedt E; Lange J; Lunde KA; Liu Y; Tysnes OB; Forsgren L; Aarsland D; Neubert TA; Larsen JP; Alves G; Møller SG
Parkinsonism Relat Disord; 2019 Jul; 64():202-210. PubMed ID: 31003905
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA expression levels in Turkish patients with Parkinson's disease.
Ozdilek B; Demircan B
Int J Neurosci; 2021 Dec; 131(12):1181-1189. PubMed ID: 32546033
[TBL] [Abstract][Full Text] [Related]
16. A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
Fazeli S; Motovali-Bashi M; Peymani M; Hashemi MS; Etemadifar M; Nasr-Esfahani MH; Ghaedi K
PLoS One; 2020; 15(11):e0240855. PubMed ID: 33171483
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis.
Guévremont D; Roy J; Cutfield NJ; Williams JM
Sci Rep; 2023 Sep; 13(1):16272. PubMed ID: 37770507
[TBL] [Abstract][Full Text] [Related]
18. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
19. Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.
Vallelunga A; Ragusa M; Di Mauro S; Iannitti T; Pilleri M; Biundo R; Weis L; Di Pietro C; De Iuliis A; Nicoletti A; Zappia M; Purrello M; Antonini A
Front Cell Neurosci; 2014; 8():156. PubMed ID: 24959119
[TBL] [Abstract][Full Text] [Related]
20. Transferrin-conjugated magnetic nanoparticles for the isolation of brain-derived blood exosomal MicroRNAs: A novel approach for Parkinson's disease diagnosis.
Jang YO; Roh Y; Shin W; Jo S; Koo B; Liu H; Kim MG; Lee HJ; Qiao Z; Lee EY; Lee M; Lee J; Lee EJ; Shin Y
Anal Chim Acta; 2024 Jun; 1306():342623. PubMed ID: 38692796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
